Evogene Ltd. (EVGN) AI Dilution Summary

Estimated cash was $10,376,500 as of 2026-08-31, rolled forward from $9,316,000 at 2026-06-30 against estimated monthly burn of $658,000. The company is funding itself through its ATM program with A.G.P./Alliance Global Partners, authorised to $3,288,113; ATM sales through 2026-08-31 raised $2,376,500 net from 4,515,898 shares sold between 2026-06-30 and 2026-08-31, with sales after 2026-08-31 not yet reported.